Literature DB >> 7081362

Complications at mucous membrane donor sites.

R W Neuhaus, H I Baylis, N Shorr.   

Abstract

Full-thickness mucous membrane is an acceptable autogenous graft to replace the deficient conjunctiva resulting from intrinsic disease, surgical resection for carcinoma, or reconstruction of contracted sockets. The mouth provides an excellent source of mucous membrane graft material with few donor site complications. However, we encountered four cases of donor site complications after full-thickness mucous membrane grafting. All cases involved submucosal scarring with contracture. Because the inner aspect of the mouth is a multicontoured surface, the submucosal scarring resulted in web formation and limitation of movement of the mandible or lip. In two cases, we resected submucosal fibrotic scar tissue and designed a standard or multiple Z-plasty to release mucosal tension. This allowed a return to normal oral function.

Entities:  

Mesh:

Year:  1982        PMID: 7081362     DOI: 10.1016/s0002-9394(14)77381-7

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  4 in total

1.  Sutureless amniotic membrane transplantation following excision of ocular surface neoplasia.

Authors:  Altan Ozcan; Ebru Esen; Emine Ciloglu
Journal:  Int J Ophthalmol       Date:  2015-06-18       Impact factor: 1.779

2.  [Use of buccal mucosa in urethral surgery].

Authors:  R Stein; A Schröder; J W Thüroff
Journal:  Urologe A       Date:  2007-12       Impact factor: 0.639

3.  The reconstruction of a contracted eye socket using a post-auricular full-thickness skin graft.

Authors:  Yi Hsuan Wei; Shu Lang Liao
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-03-06       Impact factor: 3.117

Review 4.  A beginner's guide to mucous membrane grafting for lid margin keratinization: Review of indications, surgical technique and clinical outcomes.

Authors:  Swapna S Shanbhag; Swati Singh; Puduchira George Koshy; Pragnya Rao Donthineni; Sayan Basu
Journal:  Indian J Ophthalmol       Date:  2021-01-28       Impact factor: 1.848

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.